glp-1 vs glp-2 vs glp 3 Receptor Agonists as Treatments for Type 2 Diabetes Comparison of short-acting versus long-acting
Description
Recently, GLP-1 and its agonists have been found to have good neuro-regulation and protection effects in animal models (2628)
In contrast, C-terminal modifications have little impact on potency [63]
Less common risks include gallbladder disease and rare cases of pancreatitis
Youre managing everything yourself between visits
GLP-1 affects both parts of this cycle
"It's still early
